Public, NASDAQ:GENZ
NASDAQ Global Select Market
Top 10 Large Cap Stocks of the Week: CTXS, UBS, GENZ, RBS, BCS, AMP, MFC, LYG, DB, CAJ (Jul 31, 2010)
Date: Sat, 31 Jul 2010 13:55:38 GMT
Tags:
Top 10 Large Cap Stocks of the Week: CTXS, UBS, GENZ, RBS, BCS, AMP, MFC, LYG, DB, CAJ (Jul 31, 2010)
China Analyst - 8 hours ago
China Analyst - 8 hours ago
Below are the top 10 best-performing Large Cap stocks (market cap > $10 billion) for the past week. Citrix Systems, Inc. (NASDAQ:CTXS) is the 1st best-performing stock last week in this segment of ...
Sanofi's Genzyme Bid May Need to Reach $80 to Win Investors
Date: Sat, 31 Jul 2010 10:36:32 GMT
Tags:
Sanofi's Genzyme Bid May Need to Reach $80 to Win Investors
BusinessWeek - 12 hours ago
Sanofi Ready to Takeover Genzyme - French Tribune
BusinessWeek - 12 hours ago
By Elizabeth Lopatto July 31 (Bloomberg) -- Sanofi-Aventis SA may have to pay at least $80 a share, or $21.3 billion, to acquire genetic-disease drugmaker Genzyme Corp. as activist directors drive ...
Sanofi Bid for Genzyme Bid May Need to Be Higher Than $80 to Win Investors - BloombergSanofi Ready to Takeover Genzyme - French Tribune
Sanofi readies deal for Genzyme
Date: Fri, 30 Jul 2010 23:39:53 GMT
Tags:
Sanofi readies deal for Genzyme
Investor's Business Daily - 22 hours ago
Investor's Business Daily - 22 hours ago
Investor's Business Daily, IBD and CAN SLIM and their corresponding logos are registered trademarks of Data Analysis Inc.
S&P 500: Genzyme best, Weyerhaeuser worst for July
Date: Fri, 30 Jul 2010 19:00:28 GMT
Tags:
S&P 500: Genzyme best, Weyerhaeuser worst for July
MarketWatch - Jul 30, 2010
MarketWatch - Jul 30, 2010
By Catherine Carlock, MarketWatch SAN FRANCISCO (MarketWatch) -- As US stocks made a comeback in July, some biotech, resource and industrial stocks lapped the broad market -- and several health ...
Biogen-Idec (NASDAQ:BIIB): Porges Downgrdes To Underweight, $51 Target
Date: Fri, 30 Jul 2010 13:56:18 GMT
Tags:
Biogen-Idec (NASDAQ:BIIB): Porges Downgrdes To Underweight, $51 Target
istockAnalyst.com - Jul 30, 2010
istockAnalyst.com - Jul 30, 2010
Bernstein's Geoffrey Porges is making a significant call in Biogen-Idec (NASDAQ:BIIB) downgrading the name to Underperform from Market Perform with a $51 price target (prev. $57) After all the ...
Best and worst U.S. stocks in July (at MarketWatch)
Date: Fri, 30 Jul 2010 23:58:00 GMT
Tags:
Here's a list of the best and worst performing stocks within the S&P 500 for July.
Winners & Losers From The Week That Was (at The Wall Street Journal)
Date: Fri, 30 Jul 2010 21:52:06 GMT
Tags:
What Happened to the Sanofi-Genzyme "Bear Hug" Letter? (at The Wall Street Journal)
Date: Fri, 30 Jul 2010 21:41:33 GMT
Tags:
WEEKAHEAD-The view from Reuters editors in the Americas (at Reuters)
Date: Fri, 30 Jul 2010 21:01:43 GMT
Tags:
Friday Options Recap (at Seeking Alpha)
Date: Fri, 30 Jul 2010 20:07:12 GMT
Tags: